Collaboration - February 10, 2021
Nanoform and Herantis sign Biologics Proof of Concept Agreement
Nanoform Finland and Herantis Pharma have announced that they have signed a Biologics Proof of Concept Agreement for formulation Proof of Concept projects (PoCs) aiming to enhance nasal drug delivery to the brain of Herantis’ CDNF therapies for Parkinson’s disease using Nanoform’s biological nanoparticle technology. The agreed and non-exclusive collaboration is intended to assess the […]
In a new job - October 30, 2020
Herantis appoints new Chief Financial Officer
Herantis Pharma has appointed Tone Kvåle as Chief Financial Officer and member of the management team, effective immediately. “We are delighted to welcome Tone to Herantis’ management team. She brings considerable financial acumen, public company biotech experience, and strategic skills that will be invaluable to the company. Tone’s joining comes as Herantis enters its next […]